Discover published sets by community

AMD can significantly impact a person's lifestyle, making it difficult to perform tasks that require sharp vision, such as driving, reading, and recognizing faces. This can lead to a reduction in quality of life and independence.

Ongoing research in the field of ophthalmology is focused on developing new treatments for AMD, including gene therapies, stem cell treatments, and retinal implants that may offer hope for better management of the condition in the future.

There is no cure for dry AMD, but progression can sometimes be slowed with nutritional supplements that contain antioxidants and zinc. A healthy diet and lifestyle changes are also recommended.

Diagnosis of AMD is generally done through a comprehensive eye exam that includes a visual acuity test, dilated eye exam, and possibly imaging tests like fluorescein angiography or optical coherence tomography (OCT).

Risk factors for developing AMD include age, smoking, high blood pressure, obesity, a diet high in saturated fat, and having a family history of the disease.

Macular degeneration, also known as age-related macular degeneration (AMD), is a common eye disorder that can result in vision loss. It primarily affects the central part of the retina, called the macula, which is responsible for detailed central vision used in tasks such as reading and driving.

Symptoms of AMD may include blurriness, dark areas or distortion in the central vision, and difficulty recognizing faces. Peripheral vision is generally not affected.

Genetic factors play a significant role in AMD, with certain gene variations increasing the risk of developing the condition. Genetic testing is becoming more common in understanding an individual's risk.

Patients with AMD might use low vision aids, including magnifying glasses, special eyeglass lenses, and electronic devices that can help make the most of their remaining vision.

There are two main types of AMD: dry (atrophic) and wet (neovascular or exudative). Dry AMD is more common and less severe, while wet AMD is less common but can lead to more rapid and severe vision loss.

Wet AMD can often be treated with injections into the eye of anti-VEGF (Anti-Vascular Endothelial Growth Factor) medications. These treatments aim to stop new blood vessels from forming and prevent further damage to the retina.